Annotation Detail for FASN
Basic Information Top
Gene Symbol: | FASN ( FAS,MGC14367,MGC15706,OA-519,SDR27X1 ) |
---|---|
Gene Full Name: | fatty acid synthase |
Band: | 17q25.3 |
Quick Links | Entrez ID:2194; OMIM: 600212; Uniprot ID:FAS_HUMAN; ENSEMBL ID: ENSG00000169710; HGNC ID: 3594 |
Relate to Another Database: | SFARIGene; denovo-db |
Pathway ID | Pathway Name |
---|---|
PWY-5994 | palmitate biosynthesis I (animals) |
PWY-5966 | fatty acid biosynthesis initiation II |
Pathway ID | Pathway Name |
---|---|
hsa04910 | Insulin signaling pathway |
hsa01100 | Metabolic pathways |
hsa00061 | Fatty acid biosynthesis |
Pathway ID | Pathway Name |
---|---|
Metabolism of vitamins and cofactors | |
Metabolism of lipids and lipoproteins | |
Integration of energy metabolism |
No data |
No data |
Pathway ID | Pathway Name |
---|---|
500597 | Vitamin B5 (pantothenate) metabolism |
500801 | Fatty Acyl-CoA Biosynthesis |
500721 | ChREBP activates metabolic gene expression |
Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
---|---|---|---|---|
C049325 | 1,2-dithiol-3-thione | 1,2-dithiol-3-thione results in decreased expression of FASN mRNA | decreases expression | 15302862 |
C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of FASN mRNA | decreases expression | 20005886 |
C016403 | 2,4-dinitrotoluene | 2,4-dinitrotoluene affects the expression of FASN mRNA | affects expression | 21346803 |
C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene results in decreased expression of FASN mRNA | decreases expression | 20406850 |
C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of FASN mRNA | affects expression | 21346803 |
C406734 | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid binds to and results in decreased activity of FASN protein | affects binding|decreases activity | 17847090 |
C406734 | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein | decreases activity | 15707987 14736702 |
C406734 | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of FASN mRNA | decreases expression | 15707987 |
C406734 | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased activity of FASN protein | decreases activity | 17283163 |
C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of FASN protein | increases expression | 18413838 |
C002202 | 4-oxoretinoic acid | 4-oxoretinoic acid results in increased expression of FASN mRNA | increases expression | 15982314 |
D000082 | Acetaminophen | Acetaminophen affects the expression of FASN mRNA | affects expression | 17562736 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of FASN mRNA | decreases expression | 17522070 15084756 |
C103303 | alitretinoin | alitretinoin results in decreased expression of FASN mRNA | decreases expression | 15982314 |
D013196 | Dihydrotestosterone | Dihydrotestosterone results in increased expression of FASN mRNA | increases expression | 16990341 |
C004984 | apocarotenal | apocarotenal results in decreased expression of FASN mRNA | decreases expression | 17034753 |
D001554 | Benzene | Benzene results in decreased expression of FASN mRNA | decreases expression | 15878777 |
C013894 | beta-conglycinin protein, Glycine max | beta-conglycinin protein, Glycine max results in decreased activity of FASN protein | decreases activity | 20148945 |
C013894 | beta-conglycinin protein, Glycine max | beta-conglycinin protein, Glycine max binds to and results in decreased activity of FASN protein | affects binding|decreases activity | 20148945 |
C095105 | bexarotene | bexarotene results in increased expression of FASN mRNA | increases expression | 16648578 |
D001629 | Bezafibrate | Bezafibrate results in increased expression of FASN mRNA | increases expression | 17118139 |
C006780 | bisphenol A | bisphenol A results in increased expression of FASN mRNA | increases expression | 20019905 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of FASN mRNA | decreases expression | 17522070 16239168 19224547 |
D002569 | Cerulenin | Cerulenin results in decreased activity of FASN protein | decreases activity | 12798352 |
D002569 | Cerulenin | [Cerulenin results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine | decreases abundance|decreases activity | 18723500 |
D002569 | Cerulenin | Cerulenin results in decreased activity of FASN protein | decreases activity | 15707987 |
D002569 | Cerulenin | Cerulenin results in decreased expression of FASN mRNA | decreases expression | 15707987 |
D002569 | Cerulenin | Cerulenin results in decreased activity of FASN protein | decreases activity | 20805790 17283163 20372807 |
D002994 | Clofibrate | Clofibrate results in decreased expression of FASN mRNA | decreases expression | 17522070 19224547 |
D003024 | Clozapine | Clozapine results in increased expression of FASN mRNA | increases expression | 16027736 17052361 |
D003314 | Corn Oil | Corn Oil affects the expression of FASN mRNA | affects expression | 16360708 |
C030123 | coumarin | coumarin affects the expression of FASN mRNA | affects expression | 16963487 |
D003513 | Cycloheximide | Cycloheximide inhibits the reaction [Calcitriol results in decreased expression of FASN mRNA] | decreases expression|decreases reaction | 12798352 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of FASN mRNA | decreases expression | 20106945 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of FASN mRNA | decreases expression | 19224547 |
D018119 | Stavudine | [Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 11741158 |
D018119 | Stavudine | [Stavudine co-treated with Lamivudine] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 11741158 |
D018119 | Stavudine | Stavudine results in decreased expression of FASN protein | decreases expression | 15722030 |
D003907 | Dexamethasone | Dexamethasone results in increased expression of FASN mRNA | increases expression | 17522070 |
D019259 | Lamivudine | [Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 11741158 |
D019259 | Lamivudine | [Stavudine co-treated with Lamivudine] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 11741158 |
D019259 | Lamivudine | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 11741158 |
D019259 | Lamivudine | [Zidovudine co-treated with Lamivudine] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 11741158 |
D004041 | Dietary Fats | [Fructose co-treated with Dietary Fats co-treated with TO-901317] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 19509184 |
D004041 | Dietary Fats | Dietary Fats results in decreased expression of FASN mRNA | decreases expression | 18042831 18457598 |
D004041 | Dietary Fats | Dietary Fats results in increased expression of FASN mRNA | increases expression | 18292748 21332399 17932310 |
D004041 | Dietary Fats | PPARGC1B protein promotes the reaction [Dietary Fats results in increased expression of FASN mRNA] | increases expression|increases reaction | 17932310 |
D004041 | Dietary Fats | Dietary Fats analog results in decreased expression of FASN mRNA | decreases expression | 12669817 |
D002117 | Calcitriol | Calcitriol results in decreased expression of FASN mRNA | decreases expression | 12798352 |
D002117 | Calcitriol | Cycloheximide inhibits the reaction [Calcitriol results in decreased expression of FASN mRNA] | decreases expression|decreases reaction | 12798352 |
D004317 | Doxorubicin | Doxorubicin results in increased expression of FASN mRNA | increases expression | 17089011 |
D004317 | Doxorubicin | FASN protein inhibits the reaction [Doxorubicin results in increased cleavage of PARP1 protein] | decreases reaction|increases cleavage | 18281512 |
D004317 | Doxorubicin | FASN protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 18281512 |
D004317 | Doxorubicin | orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 18281512 |
C045651 | epigallocatechin gallate | epigallocatechin gallate results in decreased expression of FASN mRNA | decreases expression | 16988119 |
D004918 | Erythromycin Estolate | Erythromycin Estolate results in decreased expression of FASN mRNA | decreases expression | 17522070 |
D004958 | Estradiol | Estradiol results in decreased expression of FASN mRNA | decreases expression | 20106945 |
D000431 | Ethanol | Ethanol inhibits the reaction [Fish Oils results in decreased expression of FASN mRNA] | decreases expression|decreases reaction | 18620774 |
D000431 | Ethanol | Ethanol inhibits the reaction [pirinixic acid results in decreased expression of FASN mRNA] | decreases expression|decreases reaction | 18620774 |
D000431 | Ethanol | Ethanol results in increased expression of FASN mRNA | increases expression | 18620774 |
D000431 | Ethanol | [Fish Oils co-treated with Ethanol] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 17347304 |
D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of FASN mRNA | affects cotreatment|decreases expression | 17942748 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of FASN mRNA | affects expression | 16079270 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of FASN mRNA | decreases expression | 15953391 17108234 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of FASN mRNA | increases expression | 16174780 |
D005047 | Etoposide | Etoposide results in increased expression of FASN mRNA | increases expression | 17089011 |
D005227 | Fatty Acids | FASN protein results in increased chemical synthesis of Fatty Acids | increases chemical synthesis | 18723500 |
D005227 | Fatty Acids | [orlistat results in decreased activity of FASN protein] which results in decreased abundance of Fatty Acids | decreases abundance|decreases activity | 18723500 |
D005227 | Fatty Acids | [orlistat results in decreased activity of FASN protein] which results in decreased chemical synthesis of Fatty Acids | decreases activity|decreases chemical synthesis | 17012255 |
D005230 | Fatty Acids, Nonesterified | [orlistat results in decreased activity of FASN protein] which affects the abundance of Fatty Acids, Nonesterified | affects abundance|decreases activity | 21213365 |
D011345 | Fenofibrate | Fenofibrate results in increased expression of FASN mRNA | increases expression | 17118139 |
D005395 | Fish Oils | Ethanol inhibits the reaction [Fish Oils results in decreased expression of FASN mRNA] | decreases expression|decreases reaction | 18620774 |
D005395 | Fish Oils | Fish Oils results in decreased expression of FASN mRNA | decreases expression | 18620774 |
D005395 | Fish Oils | [Fish Oils co-treated with Ethanol] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 17347304 |
D005395 | Fish Oils | Fish Oils results in decreased expression of FASN mRNA | decreases expression | 15654130 |
D005632 | Fructose | [Fructose co-treated with Dietary Fats co-treated with TO-901317] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 19509184 |
D005632 | Fructose | Fructose results in increased expression of FASN mRNA | increases expression | 15066988 |
D005632 | Fructose | SCD1 gene mutant form inhibits the reaction [Fructose results in increased expression of FASN mRNA] | decreases reaction|increases expression | 15066988 |
D005632 | Fructose | Triolein inhibits the reaction [SCD1 gene mutant form inhibits the reaction [Fructose results in increased expression of FASN mRNA]] | decreases reaction|increases expression | 15066988 |
D005632 | Fructose | Triolein promotes the reaction [Fructose results in increased expression of FASN mRNA] | increases expression|increases reaction | 15066988 |
D005632 | Fructose | Fructose results in increased activity of FASN protein | increases activity | 9566986 8759368 |
D005632 | Fructose | Fructose results in increased expression of FASN mRNA | increases expression | 19193814 18346472 12065722 19196556 19053045 9566986 8759368 |
D005632 | Fructose | rosiglitazone inhibits the reaction [Fructose results in increased expression of FASN mRNA] | decreases reaction|increases expression | 19196556 |
D005632 | Fructose | Tea inhibits the reaction [Fructose results in increased expression of FASN mRNA] | decreases reaction|increases expression | 19193814 |
C070081 | fulvestrant | fulvestrant inhibits the reaction [Norethynodrel results in increased activity of FASN protein] | decreases reaction|increases activity | 15870863 |
D005947 | Glucose | Glucose results in increased expression of FASN mRNA | increases expression | 15066988 |
D006220 | Haloperidol | Haloperidol results in increased expression of FASN mRNA | increases expression | 16027736 |
D007052 | Ibuprofen | Ibuprofen affects the expression of FASN protein | affects expression | 18351690 |
D007052 | Ibuprofen | Ibuprofen results in decreased expression of FASN mRNA | decreases expression | 18351690 |
D019469 | Indinavir | Indinavir results in increased expression of FASN mRNA | increases expression | 11741158 |
D019469 | Indinavir | [Stavudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 11741158 |
D019469 | Indinavir | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 11741158 |
C054164 | lipstatin | lipstatin analog binds to FASN protein | affects binding | 20577697 |
C445068 | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in decreased expression of FASN mRNA | decreases expression | 20372807 |
D008767 | Methylmercury Compounds | Methylmercury Compounds results in decreased expression of FASN mRNA | decreases expression | 16966085 |
D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in increased expression of FASN mRNA | increases expression | 12634122 |
D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of FASN mRNA | increases expression | 16525678 |
D015741 | Metribolone | Metribolone promotes the reaction [NDRG1 protein binds to FASN protein] | affects binding|increases reaction | 17220478 |
D015741 | Metribolone | Metribolone results in increased expression of FASN protein | increases expression | 17152098 |
D015735 | Mifepristone | Mifepristone inhibits the reaction [Norethynodrel results in increased activity of FASN protein] | decreases reaction|increases activity | 15870863 |
D008942 | Mitoxantrone | FASN protein results in decreased susceptibility to Mitoxantrone | decreases response to substance | 18281512 |
D008942 | Mitoxantrone | orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Mitoxantrone] | decreases reaction|decreases response to substance | 18281512 |
D009270 | Naloxone | Naloxone results in decreased expression of FASN mRNA | decreases expression | 17522070 |
C029938 | nickel sulfate | nickel sulfate results in increased expression of FASN mRNA | increases expression | 16780908 |
C029938 | nickel sulfate | nickel sulfate results in decreased expression of FASN mRNA | decreases expression | 16100012 |
C002741 | N-nitrosomorpholine | N-nitrosomorpholine results in increased expression of FASN mRNA | increases expression | 15543204 |
C002741 | N-nitrosomorpholine | N-nitrosomorpholine results in increased expression of FASN protein | increases expression | 15543204 |
D009640 | Norethindrone | Norethindrone results in increased activity of FASN protein | increases activity | 15870863 |
D009641 | Norethynodrel | fulvestrant inhibits the reaction [Norethynodrel results in increased activity of FASN protein] | decreases reaction|increases activity | 15870863 |
D009641 | Norethynodrel | Mifepristone inhibits the reaction [Norethynodrel results in increased activity of FASN protein] | decreases reaction|increases activity | 15870863 |
D009641 | Norethynodrel | Norethynodrel results in increased activity of and results in increased expression of FASN protein | increases activity|increases expression | 15870863 |
C055122 | orlistat | orlistat analog binds to FASN protein | affects binding | 20577697 |
C055122 | orlistat | orlistat analog results in decreased activity of FASN protein | decreases activity | 18710210 |
C055122 | orlistat | orlistat binds to and results in decreased activity of FASN protein | affects binding|decreases activity | 17847090 17618296 20148945 |
C055122 | orlistat | orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 18281512 |
C055122 | orlistat | orlistat inhibits the reaction [FASN protein results in decreased susceptibility to Mitoxantrone] | decreases reaction|decreases response to substance | 18281512 |
C055122 | orlistat | orlistat results in decreased activity of FASN protein | decreases activity | 18723500 18710210 17012255 |
C055122 | orlistat | [orlistat results in decreased activity of FASN protein] which results in decreased abundance of Fatty Acids | decreases abundance|decreases activity | 18723500 |
C055122 | orlistat | [orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphatidylcholines | decreases abundance|decreases activity | 18723500 |
C055122 | orlistat | [orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine | decreases abundance|decreases activity | 18723500 |
C055122 | orlistat | [orlistat results in decreased activity of FASN protein] which results in decreased chemical synthesis of Fatty Acids | decreases activity|decreases chemical synthesis | 17012255 |
C055122 | orlistat | orlistat inhibits the reaction [FASN protein results in increased chemical synthesis of Palmitic Acid] | decreases reaction|increases chemical synthesis | 21213365 |
C055122 | orlistat | orlistat results in decreased activity of FASN protein | decreases activity | 21213365 |
C055122 | orlistat | [orlistat results in decreased activity of FASN protein] which affects the abundance of Fatty Acids, Nonesterified | affects abundance|decreases activity | 21213365 |
C055122 | orlistat | orlistat results in decreased activity of FASN protein | decreases activity | 17283163 20372807 20805790 18770866 16986934 18796435 |
D010126 | Ozone | Ozone results in decreased expression of FASN mRNA | decreases expression | 16716893 |
D010168 | Palmitates | Palmitates binds to FASN protein | affects binding | 17847090 |
D010168 | Palmitates | FASN protein results in increased chemical synthesis of Palmitates | increases chemical synthesis | 17283163 |
D019308 | Palmitic Acid | orlistat inhibits the reaction [FASN protein results in increased chemical synthesis of Palmitic Acid] | decreases reaction|increases chemical synthesis | 21213365 |
D019308 | Palmitic Acid | FASN protein results in increased chemical synthesis of Palmitic Acid | increases chemical synthesis | 21213365 18281512 20805790 |
C041786 | palm oil | palm oil results in decreased expression of FASN mRNA | decreases expression | 18042831 |
D010713 | Phosphatidylcholines | [orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphatidylcholines | decreases abundance|decreases activity | 18723500 |
D010767 | Phosphorylcholine | [Cerulenin results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine | decreases abundance|decreases activity | 18723500 |
D010767 | Phosphorylcholine | [orlistat results in decreased activity of FASN protein] which results in decreased abundance of Phosphorylcholine | decreases abundance|decreases activity | 18723500 |
C006253 | pirinixic acid | Ethanol inhibits the reaction [pirinixic acid results in decreased expression of FASN mRNA] | decreases expression|decreases reaction | 18620774 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of FASN mRNA | decreases expression | 18620774 |
C006253 | pirinixic acid | pirinixic acid results in increased expression of FASN mRNA | increases expression | 18301758 20059764 17118139 15375163 15302862 15777286 |
C006253 | pirinixic acid | PPARA protein affects the reaction [pirinixic acid results in increased expression of FASN mRNA] | affects reaction|increases expression | 15777286 |
C006253 | pirinixic acid | PPARA protein promotes the reaction [pirinixic acid results in increased expression of FASN mRNA] | increases expression|increases reaction | 20059764 |
C006253 | pirinixic acid | [[[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides | affects binding|decreases abundance|decreases activity|decreases expression|decreases localization|increases activity | 19248225 |
D011794 | Quercetin | Quercetin results in decreased expression of FASN mRNA | decreases expression | 19729006 |
D011794 | Quercetin | Quercetin results in decreased activity of FASN protein | decreases activity | 17032037 |
D011794 | Quercetin | Quercetin results in decreased expression of FASN mRNA | decreases expression | 17032037 |
C059514 | resveratrol | resveratrol inhibits the reaction [INS1 protein results in increased expression of FASN mRNA] | decreases reaction|increases expression | 16626303 |
C059514 | resveratrol | resveratrol results in decreased expression of FASN mRNA | decreases expression | 16626303 |
D015474 | Isotretinoin | Isotretinoin results in decreased expression of FASN mRNA | decreases expression | 15982314 |
C089730 | rosiglitazone | rosiglitazone inhibits the reaction [Fructose results in increased expression of FASN mRNA] | decreases reaction|increases expression | 19196556 |
D012402 | Rotenone | Rotenone results in decreased expression of FASN mRNA | decreases expression | 19693701 19013527 |
D012643 | Selenium | Selenium results in increased expression of FASN mRNA | increases expression | 19244175 |
D012643 | Selenium | Selenium results in increased expression of FASN mRNA | increases expression | 19022953 |
D012822 | Silicon Dioxide | Silicon Dioxide results in increased activity of FASN protein | increases activity | 1647683 |
D013311 | Streptozocin | GHRL protein promotes the reaction [Streptozocin results in decreased expression of FASN mRNA] | decreases expression|increases reaction | 20219977 |
D013311 | Streptozocin | INS protein inhibits the reaction [Streptozocin results in decreased expression of FASN mRNA] | decreases expression|decreases reaction | 20219977 |
D013311 | Streptozocin | Streptozocin results in decreased expression of FASN mRNA | decreases expression | 20219977 |
D014284 | Triiodothyronine | Triiodothyronine results in increased expression of FASN mRNA | increases expression | 15953391 |
D013629 | Tamoxifen | Tamoxifen results in decreased expression of FASN mRNA | decreases expression | 19224547 |
D013662 | Tea | Tea inhibits the reaction [Fructose results in increased expression of FASN mRNA] | decreases reaction|increases expression | 19193814 |
D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of FASN mRNA | affects cotreatment|decreases expression | 17942748 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | decreases expression | 16960034 20005886 15800033 18295293 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FASN mRNA | decreases expression | 16054898 16960034 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of FASN protein | decreases expression | 16548065 |
D013752 | Tetracycline | Tetracycline results in decreased expression of FASN mRNA | decreases expression | 19224547 17522070 |
C423915 | TO-901317 | TO-901317 results in increased expression of FASN mRNA | increases expression | 15548517 |
C423915 | TO-901317 | [Fructose co-treated with Dietary Fats co-treated with TO-901317] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 19509184 |
C423915 | TO-901317 | TO-901317 results in increased expression of FASN mRNA | increases expression | 15302862 |
C496197 | trans-10,cis-12-conjugated linoleic acid | trans-10,cis-12-conjugated linoleic acid results in decreased expression of FASN mRNA | decreases expression | 16988111 |
C496197 | trans-10,cis-12-conjugated linoleic acid | trans-10,cis-12-conjugated linoleic acid results in increased expression of FASN mRNA | increases expression | 17217560 |
D014212 | Tretinoin | Tretinoin metabolite results in increased expression of FASN mRNA | increases expression | 15982314 |
D014212 | Tretinoin | Tretinoin results in decreased expression of FASN mRNA | decreases expression | 15982314 |
D014260 | Triclosan | Triclosan results in decreased activity of FASN protein | decreases activity | 15707987 |
D014260 | Triclosan | Triclosan results in decreased expression of FASN mRNA | decreases expression | 15707987 |
D014260 | Triclosan | Triclosan results in decreased activity of FASN protein | decreases activity | 15358634 |
D014280 | Triglycerides | [[[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides | affects binding|decreases abundance|decreases activity|decreases expression|decreases localization|increases activity | 19248225 |
D014280 | Triglycerides | [[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides | affects binding|decreases abundance|decreases activity|decreases expression|decreases localization|increases activity | 19248225 |
D014304 | Triolein | Triolein inhibits the reaction [SCD1 gene mutant form inhibits the reaction [Fructose results in increased expression of FASN mRNA]] | decreases reaction|increases expression | 15066988 |
D014304 | Triolein | Triolein promotes the reaction [Fructose results in increased expression of FASN mRNA] | increases expression|increases reaction | 15066988 |
C057693 | troglitazone | [[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides | affects binding|decreases abundance|decreases activity|decreases expression|decreases localization|increases activity | 19248225 |
D014520 | Urethane | Urethane results in increased expression of FASN protein | increases expression | 18413838 |
C054478 | valilactone | valilactone results in decreased activity of FASN protein | decreases activity | 18710210 |
C054478 | valilactone | valilactone results in decreased activity of FASN protein | decreases activity | 16986934 |
D014635 | Valproic Acid | Valproic Acid results in increased expression of FASN mRNA | increases expression | 15345369 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of FASN mRNA | decreases expression | 19224547 |
D015215 | Zidovudine | Zidovudine affects the expression of FASN mRNA | affects expression | 20032539 |
D015215 | Zidovudine | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 11741158 |
D015215 | Zidovudine | [Zidovudine co-treated with Lamivudine] results in increased expression of FASN mRNA | affects cotreatment|increases expression | 11741158 |
D015215 | Zidovudine | Zidovudine results in decreased expression of FASN protein | decreases expression | 15722030 |
D015032 | Zinc | Zinc affects the activity of FASN protein | affects activity | 17181878 |
Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
---|---|---|---|---|---|
MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 3.71 | 14745880 | |
MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 13.72 | 18926900 17676605 | |
MESH:D000014 | Abnormalities, Drug-Induced | Isotretinoin | 13.72 | 18769834 | |
MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 13.72 | 14514962 15322242 11752688 | |
MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 13.72 | 8875741 | |
MESH:D000015 | Abnormalities, Multiple | Isotretinoin | 7.92 | 18769834 | |
MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 7.92 | 19490988 | |
MESH:D000138 | Acidosis | Ethanol | 3.67 | 11192467 | |
MESH:D017486 | Acneiform Eruptions | Isotretinoin | 5.44 | 16232082 | |
MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 9.21 | 17505938 | |
MESH:D000152 | Acne Vulgaris | Isotretinoin | 9.21 | 16185265 18769834 | |
MESH:D000163 | Acquired Immunodeficiency Syndrome | Zidovudine | 4.02 | 9612607 | |
MESH:D000169 | Acrodermatitis | Zinc | 4.57 | 17190629 17202136 16889938 | |
MESH:D058186 | Acute Kidney Injury | Ibuprofen | 6.59 | 6375363 | |
MESH:D058186 | Acute Kidney Injury | resveratrol | 6.59 | 16538975 | |
MESH:D055371 | Acute Lung Injury | nickel sulfate | 6.60 | 12718980 19131640 16100012 11954676 | |
MESH:D055371 | Acute Lung Injury | pirinixic acid | 6.60 | 18653653 | |
MESH:D000230 | Adenocarcinoma | Doxorubicin | 13.10 | 17418594 | |
MESH:D000230 | Adenocarcinoma | Estradiol | 13.10 | 11473722 | |
MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 13.10 | 14692618 | |
MESH:D000230 | Adenocarcinoma | Ibuprofen | 13.10 | 10697514 | |
MESH:D000230 | Adenocarcinoma | Methylnitrosourea | 13.10 | 15113128 15688392 | |
MESH:D000230 | Adenocarcinoma | Urethane | 13.10 | 18316556 | |
MESH:D002282 | Adenocarcinoma, Bronchiolo-Alveolar | Urethane | 4.87 | 15814487 | |
MESH:D000236 | Adenoma | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 8.33 | 16176798 | |
MESH:D000236 | Adenoma | resveratrol | 8.33 | 15688382 | |
MESH:D000236 | Adenoma | Urethane | 8.33 | 17093202 16926031 11497255 10822126 10530776 6695378 17195641 | |
MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 7.17 | 16434500 | |
MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 7.17 | 16835633 | |
MESH:D000380 | Agranulocytosis | Clozapine | 4.25 | 14617031 16160616 12649775 | |
MESH:D000419 | Albuminuria | Doxorubicin | 3.75 | 21441931 | |
MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 4.48 | 15451039 15451040 | |
MESH:D000505 | Alopecia | Tretinoin | 2.93 | 15955085 | |
MESH:D000544 | Alzheimer Disease | Ibuprofen | 9.51 | 18351690 | |
MESH:D000544 | Alzheimer Disease | Ozone | 9.51 | 15513908 | |
MESH:D000544 | Alzheimer Disease | resveratrol | 9.51 | 16162502 16183991 | |
MESH:D000544 | Alzheimer Disease | rosiglitazone | 9.51 | 19621015 | |
MESH:D000544 | Alzheimer Disease | Zinc | 9.51 | 16580781 17119284 16410023 16325427 | |
MESH:D000550 | Amblyopia | Valproic Acid | 4.39 | 17688650 | |
MESH:D000707 | Anaphylaxis | Ibuprofen | 4.44 | 9532969 | |
MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 2.22 | 11748828 | |
MESH:D000741 | Anemia, Aplastic | Benzene | 3.70 | 17661222 14761424 11369114 | |
MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.49 | 17084956 | |
MESH:D000755 | Anemia, Sickle Cell | Zinc | 4.11 | 16916123 | |
MESH:D000799 | Angioedema | Acetaminophen | 3.00 | 10982225 | |
MESH:D000853 | Anophthalmos | Ethanol | 4.01 | 15513904 | |
MESH:D001008 | Anxiety Disorders | Ethanol | 6.72 | 11141031 | |
MESH:D001008 | Anxiety Disorders | Valproic Acid | 6.72 | 17497229 | |
MESH:D001161 | Arteriosclerosis | Dietary Fats | 7.24 | 15238619 | |
MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 7.24 | 11256880 | |
MESH:D001169 | Arthritis, Experimental | Dexamethasone | 12.83 | 17659584 | |
MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 12.83 | 15885639 | |
MESH:D001169 | Arthritis, Experimental | resveratrol | 12.83 | 17115116 | |
MESH:D001169 | Arthritis, Experimental | Tretinoin | 12.83 | 16412693 | |
MESH:D001172 | Arthritis, Rheumatoid | Ozone | 3.71 | 15570426 | |
MESH:D001172 | Arthritis, Rheumatoid | Tretinoin | 3.71 | 16292516 | |
MESH:D001249 | Asthma | epigallocatechin gallate | 8.43 | 16516891 | |
MESH:D001249 | Asthma | Ozone | 8.43 | 16373670 17854713 | |
MESH:D001249 | Asthma | Tretinoin | 8.43 | 16456186 | |
MESH:D001249 | Asthma | Zinc | 8.43 | 17085522 | |
MESH:D001260 | Ataxia Telangiectasia | Quercetin | 4.15 | 15336622 | |
MESH:D050197 | Atherosclerosis | resveratrol | 2.74 | 17967414 16873680 | |
MESH:D001284 | Atrophy | fulvestrant | 4.06 | 11514358 | |
MESH:D001321 | Autistic Disorder | Acetaminophen | 2.00 | 18445737 | |
MESH:D001321 | Autistic Disorder | Haloperidol | 2.00 | 19368416 18080171 | |
MESH:D001321 | Autistic Disorder | Valproic Acid | 2.00 | 18985861 15238991 18177632 17507914 16609825 18316065 18558336 20603192 18940202 18396377 18775368 17157402 19232924 19460635 17688650 | |
MESH:D001327 | Autoimmune Diseases | epigallocatechin gallate | 8.40 | 19761891 | |
MESH:D001327 | Autoimmune Diseases | Quercetin | 8.40 | 19761891 | |
MESH:D001471 | Barrett Esophagus | Tretinoin | 3.61 | 16935849 | |
MESH:D001714 | Bipolar Disorder | Valproic Acid | 2.58 | 17594078 20046352 | |
MESH:D001778 | Blood Coagulation Disorders | Clofibrate | 15.85 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 15.85 | 19483382 | |
MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 15.85 | 12125929 | |
MESH:D001778 | Blood Coagulation Disorders | Tretinoin | 15.85 | 16206674 16197459 | |
MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.95 | 15340226 | |
MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 6.05 | 15746008 | |
MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 6.05 | 8888407 | |
MESH:D001855 | Bone Marrow Diseases | Benzene | 4.39 | 16183116 | |
MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 9.37 | 14601052 | |
MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 9.37 | 14601052 | |
MESH:D001862 | Bone Resorption | bisphenol A | 3.12 | 11985600 | |
MESH:D001930 | Brain Injuries | Zinc | 3.88 | 17109824 | |
MESH:D002545 | Brain Ischemia | Ibuprofen | 7.80 | 15837124 | |
MESH:D002545 | Brain Ischemia | resveratrol | 7.80 | 17600658 | |
MESH:D001932 | Brain Neoplasms | Doxorubicin | 3.09 | 17150277 | |
MESH:D001943 | Breast Neoplasms | marker/mechanism | 17089011 18281512 | ||
MESH:D001943 | Breast Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 14.52 | 20146248 | |
MESH:D001943 | Breast Neoplasms | alitretinoin | 14.52 | 16344269 | |
MESH:D001943 | Breast Neoplasms | Benzene | 14.52 | 11921183 17162533 | |
MESH:D001943 | Breast Neoplasms | bexarotene | 14.52 | 16344269 16818667 | |
MESH:D001943 | Breast Neoplasms | bisphenol A | 14.52 | 17123778 | |
MESH:D001943 | Breast Neoplasms | Calcitriol | 14.52 | 11237771 | |
MESH:D001943 | Breast Neoplasms | Dietary Fats | 14.52 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Doxorubicin | 14.52 | 17426702 15136595 16826403 18695136 17369602 19526202 15634643 15939500 18382427 16264153 15993339 16096432 15994142 18628466 15567936 17983394 16595493 16935488 11325840 15668708 16322301 18234424 16115903 15692762 | |
MESH:D001943 | Breast Neoplasms | Estradiol | 14.52 | 17261762 14630087 19861407 18497071 17289903 16675129 12948864 17018787 | |
MESH:D001943 | Breast Neoplasms | Etoposide | 14.52 | 16322251 | |
MESH:D001943 | Breast Neoplasms | fulvestrant | 14.52 | 18984771 | |
MESH:D001943 | Breast Neoplasms | Methylnitrosourea | 14.52 | 14633655 16253758 11306469 | |
MESH:D001943 | Breast Neoplasms | Quercetin | 14.52 | 18628248 | |
MESH:D001943 | Breast Neoplasms | resveratrol | 14.52 | 17651959 16393696 17534123 | |
MESH:D001943 | Breast Neoplasms | Tamoxifen | 14.52 | 19200415 15668708 21152245 18821012 19115204 19011961 17440819 19221464 16873071 18629630 20005174 18351453 19487384 18855134 21138602 18815881 17049068 18997820 20859285 19084267 19059307 19142967 17242785 16818667 18425577 19189212 19289846 20065188 19288272 11161223 19410462 16202921 17261762 20544844 19103187 19244106 20390343 19155303 16273361 17893378 18984771 20135344 19189210 19066611 15565566 | |
MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 14.52 | 20435547 | |
MESH:D001943 | Breast Neoplasms | Tretinoin | 14.52 | 16166294 16443354 16873071 | |
MESH:D016535 | Bronchial Hyperreactivity | Ozone | 3.00 | 17626835 18417511 16777450 15516495 19059883 18315731 14754758 | |
MESH:D001997 | Bronchopulmonary Dysplasia | Tretinoin | 3.76 | 16813970 | |
MESH:D019121 | Burkholderia Infections | orlistat | 5.80 | 17874328 | |
MESH:D002056 | Burns | Ethanol | 3.84 | 16374292 | |
MESH:D002100 | Cachexia | Ibuprofen | 9.83 | 15141370 | |
MESH:D002100 | Cachexia | Ozone | 9.83 | 16183385 | |
MESH:D002105 | Cadmium Poisoning | Quercetin | 4.70 | 16962696 | |
MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.64 | 16111702 | |
MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 2.98 | 16124888 15721981 16011737 15673190 10355542 15700767 18705752 16227642 16097048 16192424 16050911 3786805 | |
MESH:D002276 | Carcinoid Tumor | Doxorubicin | 9.90 | 16051944 | |
MESH:D002276 | Carcinoid Tumor | Streptozocin | 9.90 | 16051944 | |
MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.13 | 16835633 | |
MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.69 | 19066611 | |
MESH:D018236 | Carcinoma, Embryonal | Tretinoin | 4.31 | 16168501 | |
MESH:D006528 | Carcinoma, Hepatocellular | marker/mechanism | 15543204 | ||
MESH:D006528 | Carcinoma, Hepatocellular | 2,4-dinitrotoluene | 23.52 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 23.52 | 16705839 | |
MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 23.52 | 3084413 | |
MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 23.52 | 18788625 | |
MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 23.52 | 17876044 18059187 16023760 16234567 | |
MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 23.52 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 23.52 | 18788625 15763234 15289165 | |
MESH:D006528 | Carcinoma, Hepatocellular | N-nitrosomorpholine | 23.52 | 1917145 8364915 15010824 9466558 9029167 2885971 16935385 19335982 15543204 11509945 10629087 9311599 1701930 19383236 1967229 | |
MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 23.52 | 12508355 19519916 | |
MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 23.52 | 16227395 19321006 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 23.52 | 16924424 | |
MESH:D006528 | Carcinoma, Hepatocellular | Tretinoin | 23.52 | 1917145 | |
MESH:D002278 | Carcinoma in Situ | bisphenol A | 4.16 | 17123778 | |
MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 3.77 | 16675471 | |
MESH:D002289 | Carcinoma, Non-Small-Cell Lung | bexarotene | 2.87 | 16247446 | |
MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 4.14 | 17234771 | |
MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 5.72 | 1485588 16201981 | |
MESH:D002292 | Carcinoma, Renal Cell | N-nitrosomorpholine | 5.72 | 7921415 1429202 | |
MESH:D002294 | Carcinoma, Squamous Cell | Calcitriol | 13.64 | 11237771 | |
MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 13.64 | 6189445 | |
MESH:D002294 | Carcinoma, Squamous Cell | Isotretinoin | 13.64 | 11237771 | |
MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 13.64 | 16227395 | |
MESH:D002294 | Carcinoma, Squamous Cell | Tretinoin | 13.64 | 16051514 16096774 | |
MESH:D002294 | Carcinoma, Squamous Cell | Zinc | 13.64 | 16543248 | |
MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 2.88 | 17572228 | |
MESH:D006332 | Cardiomegaly | Ethanol | 8.37 | 19332462 | |
MESH:D006332 | Cardiomegaly | Quercetin | 8.37 | 19794523 | |
MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 8.37 | 18670907 16120746 18850075 | |
MESH:D009202 | Cardiomyopathies | Doxorubicin | 2.94 | 16455267 15505089 15792986 16364871 17007740 16109756 15811867 15476868 16278810 16731534 16242529 16651473 16612575 17131338 17382496 17519947 16952015 17308081 17928571 18627295 17351982 17329180 17924179 16269455 17974986 | |
MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 2.58 | 17334414 16243910 | |
MESH:D002318 | Cardiovascular Diseases | resveratrol | 5.59 | 15458977 | |
MESH:D002318 | Cardiovascular Diseases | Zinc | 5.59 | 16936243 | |
MESH:D002375 | Catalepsy | Haloperidol | 4.09 | 15215559 1977408 | |
MESH:D002386 | Cataract | Acetaminophen | 9.20 | 10977129 | |
MESH:D002386 | Cataract | Methylnitrosourea | 9.20 | 12484553 | |
MESH:D002386 | Cataract | Tretinoin | 9.20 | 17460283 | |
MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 18.42 | 6135515 | |
MESH:D002471 | Cell Transformation, Neoplastic | Clofibrate | 18.42 | 1399818 | |
MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 18.42 | 12371664 | |
MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 18.42 | 18566989 | |
MESH:D002471 | Cell Transformation, Neoplastic | Methylnitronitrosoguanidine | 18.42 | 2727394 | |
MESH:D002471 | Cell Transformation, Neoplastic | Methylnitrosourea | 18.42 | 2727394 7505956 | |
MESH:D018290 | Cervical Intraepithelial Neoplasia | Tretinoin | 3.76 | 16129372 | |
MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 2.33 | 20734317 | |
MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 2.45 | 16835633 | |
MESH:D002779 | Cholestasis | Cyclosporine | 9.58 | 19486331 | |
MESH:D002779 | Cholestasis | Ethinyl Estradiol | 9.58 | 17681005 17110522 16919318 11677210 16105132 17333356 15861022 | |
MESH:D002779 | Cholestasis | pirinixic acid | 9.58 | 19176532 | |
MESH:D002822 | Choriocarcinoma | Tretinoin | 4.31 | 16461808 | |
MESH:D002916 | Chylothorax | orlistat | 5.80 | 17003701 | |
MESH:D002971 | Cleft Lip | Ethanol | 3.08 | 15513904 | |
MESH:D002972 | Cleft Palate | Ethanol | 10.52 | 15513904 | |
MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 10.52 | 12621046 16354765 15668235 8697196 15340226 | |
MESH:D002972 | Cleft Palate | Tretinoin | 10.52 | 9407595 | |
MESH:D002972 | Cleft Palate | Urethane | 10.52 | 12810352 | |
MESH:D003072 | Cognition Disorders | Clozapine | 4.16 | 17123785 | |
MESH:D003092 | Colitis | resveratrol | 11.40 | 16474422 | |
MESH:D003092 | Colitis | Selenium | 11.40 | 17936198 | |
MESH:D003092 | Colitis | Tretinoin | 11.40 | 17035595 | |
MESH:D003110 | Colonic Neoplasms | Dexamethasone | 4.54 | 15824018 | |
MESH:D003110 | Colonic Neoplasms | Quercetin | 4.54 | 19056647 11134977 17148506 17191121 19440933 16640504 15741050 | |
MESH:D003110 | Colonic Neoplasms | resveratrol | 4.54 | 16338953 | |
MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 2.88 | 18802399 18259882 | |
MESH:D015179 | Colorectal Neoplasms | Quercetin | 2.88 | 18095365 18852136 | |
MESH:D015179 | Colorectal Neoplasms | resveratrol | 2.88 | 16550006 | |
MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 7.17 | 17141729 14669216 | |
MESH:D000013 | Congenital Abnormalities | Triclosan | 7.17 | 19283420 | |
MESH:D003327 | Coronary Disease | Fructose | 6.81 | 18504504 | |
MESH:D003327 | Coronary Disease | resveratrol | 6.81 | 16507316 | |
MESH:D019465 | Craniofacial Abnormalities | Benzene | 11.40 | 15643154 | |
MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 11.40 | 17728286 | |
MESH:D019465 | Craniofacial Abnormalities | Ethanol | 11.40 | 11198716 15451039 15513904 19302082 15451040 10194807 11873399 | |
MESH:D019465 | Craniofacial Abnormalities | Isotretinoin | 11.40 | 18769834 9879862 | |
MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 11.40 | 15322242 10048152 20055451 | |
MESH:D019465 | Craniofacial Abnormalities | Tretinoin | 11.40 | 17551590 9224671 10589399 9211117 8800419 9664655 9142499 16925845 9125849 14991402 | |
MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 11.40 | 16575769 8888407 17688650 | |
MESH:D019465 | Craniofacial Abnormalities | Zinc | 11.40 | 19302082 | |
MESH:D003490 | Cyanosis | 2,4-dinitrotoluene | 8.21 | 18551238 | |
MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 8.21 | 18551238 | |
MESH:D016757 | Death, Sudden, Cardiac | Haloperidol | 4.07 | 20210726 | |
MESH:D003704 | Dementia | Haloperidol | 7.95 | 11575062 | |
MESH:D003704 | Dementia | Methylmercury Compounds | 7.95 | 16140633 | |
MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.55 | 19031437 | |
MESH:D003872 | Dermatitis | Benzene | 3.96 | 15902427 | |
MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 4.80 | 12438553 | |
MESH:D017449 | Dermatitis, Allergic Contact | nickel sulfate | 4.80 | 11298694 16823706 16780908 | |
MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.97 | 18249437 | |
MESH:D048909 | Diabetes Complications | orlistat | 5.00 | 19207292 | |
MESH:D003920 | Diabetes Mellitus | rosiglitazone | 11.52 | 17446233 | |
MESH:D003920 | Diabetes Mellitus | Streptozocin | 11.52 | 16285004 | |
MESH:D003920 | Diabetes Mellitus | Zinc | 11.52 | 16479319 | |
MESH:D003921 | Diabetes Mellitus, Experimental | Fructose | 14.23 | 18603373 | |
MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 14.23 | 19496084 | |
MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 14.23 | 16873680 | |
MESH:D003921 | Diabetes Mellitus, Experimental | Streptozocin | 14.23 | 18603373 12083368 12644472 17442507 7637645 15298345 12446591 11055810 15862027 11260395 19496084 19586609 16286809 17874149 19960420 8740154 19298542 1374869 6379147 12093613 16684804 15831366 2177838 18715473 | |
MESH:D003922 | Diabetes Mellitus, Type 1 | Streptozocin | 3.31 | 18603373 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Clozapine | 19.53 | 16402076 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | coumarin | 19.53 | 19647726 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | epigallocatechin gallate | 19.53 | 16988119 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Fructose | 19.53 | 18603373 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | rosiglitazone | 19.53 | 12642470 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Streptozocin | 19.53 | 19586609 19647726 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 19.53 | 17107852 | |
MESH:D003924 | Diabetes Mellitus, Type 2 | troglitazone | 19.53 | 16023994 | |
MESH:D003925 | Diabetic Angiopathies | troglitazone | 4.83 | 12601628 | |
MESH:D058065 | Diabetic Cardiomyopathies | Streptozocin | 4.90 | 16025228 | |
MESH:D003928 | Diabetic Nephropathies | Estradiol | 15.63 | 19279558 | |
MESH:D003928 | Diabetic Nephropathies | resveratrol | 15.63 | 16286809 | |
MESH:D003928 | Diabetic Nephropathies | Streptozocin | 15.63 | 19682444 19960420 | |
MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 15.63 | 19279558 | |
MESH:D003930 | Diabetic Retinopathy | Streptozocin | 4.63 | 17662242 | |
MESH:D003967 | Diarrhea | Dexamethasone | 6.04 | 7237001 | |
MESH:D003967 | Diarrhea | orlistat | 6.04 | 20002075 | |
MESH:D006970 | Disorders of Excessive Somnolence | Clozapine | 4.71 | 15331141 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,4-dinitrotoluene | 31.59 | 18551238 21346803 | |
MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 31.59 | 18551238 21346803 | |
MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 31.59 | 18713872 17522070 14725611 11421492 16781746 14986274 10663392 19164858 12540782 10915739 15619225 15968718 12153990 17906064 11739529 12705907 11743745 19085960 10774834 11461765 19923254 19420014 14550746 16177239 2444490 19416960 16485898 16109766 17562736 11834606 11529661 12958197 19370779 16227642 16393943 16081117 12392966 18071297 11287661 19739265 12594235 | |
MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 31.59 | 6884620 7179309 15998439 9327722 3786805 16227642 10092053 4309450 6623471 10915739 3732212 2869522 7120509 15027814 19336974 21278145 11566570 17522070 19085960 7440962 16177239 15968718 | |
MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 31.59 | 17416283 | |
MESH:D056486 | Drug-Induced Liver Injury | Erythromycin Estolate | 31.59 | 14998559 17522070 | |
MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 31.59 | 11566570 | |
MESH:D056486 | Drug-Induced Liver Injury | Selenium | 31.59 | 15131321 | |
MESH:D056486 | Drug-Induced Liver Injury | Tea | 31.59 | 19370779 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 31.59 | 20420201 | |
MESH:D056486 | Drug-Induced Liver Injury | Tetracycline | 31.59 | 17522070 | |
MESH:D056486 | Drug-Induced Liver Injury | troglitazone | 31.59 | 14986274 | |
MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 31.59 | 1733752 19641884 | |
MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 3.26 | 19426721 | |
MESH:D004362 | Drug Toxicity | Doxorubicin | 18.90 | 18602426 | |
MESH:D004362 | Drug Toxicity | Lamivudine | 18.90 | 15040536 | |
MESH:D004362 | Drug Toxicity | Stavudine | 18.90 | 15040536 | |
MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 18.90 | 11462148 | |
MESH:D004362 | Drug Toxicity | Zidovudine | 18.90 | 15040536 | |
MESH:D004374 | Ductus Arteriosus, Patent | Ibuprofen | 4.79 | 18446180 16133044 18450898 | |
MESH:D050171 | Dyslipidemias | Clofibrate | 15.49 | 16707586 | |
MESH:D050171 | Dyslipidemias | Clozapine | 15.49 | 16402076 | |
MESH:D050171 | Dyslipidemias | Dietary Fats | 15.49 | 18367378 | |
MESH:D050171 | Dyslipidemias | Fenofibrate | 15.49 | 16707586 | |
MESH:D004421 | Dystonia | Valproic Acid | 3.28 | 1851702 | |
MESH:D004485 | Eczema | Dexamethasone | 3.67 | 12438553 | |
MESH:D004487 | Edema | Dexamethasone | 13.88 | 19703484 | |
MESH:D004487 | Edema | pirinixic acid | 13.88 | 12083418 | |
MESH:D004487 | Edema | resveratrol | 13.88 | 8985016 | |
MESH:D004487 | Edema | rosiglitazone | 13.88 | 12083418 | |
MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 13.88 | 11000095 12711302 | |
MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 9.15 | 18230668 16714409 15322242 | |
MESH:D004489 | Edema, Cardiac | Tretinoin | 9.15 | 18230668 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Calcitriol | 15.53 | 15138306 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 15.53 | 12538720 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 15.53 | 17872969 | |
MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 15.53 | 19031437 | |
MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 17.06 | 17359293 | |
MESH:D016889 | Endometrial Neoplasms | Estradiol | 17.06 | 11473722 18566989 19148513 | |
MESH:D016889 | Endometrial Neoplasms | Fenofibrate | 17.06 | 16569247 | |
MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 17.06 | 20544844 16202921 19155303 17893378 | |
MESH:D016889 | Endometrial Neoplasms | Tretinoin | 17.06 | 16569247 | |
MESH:D004715 | Endometriosis | Ibuprofen | 11.22 | 15652904 | |
MESH:D004715 | Endometriosis | Mifepristone | 11.22 | 16134523 | |
MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 11.22 | 9294722 10568697 | |
MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 4.31 | 18037988 | |
MESH:D019446 | Endotoxemia | Ibuprofen | 4.15 | 11545620 | |
MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 4.04 | 17923197 | |
MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 3.35 | 17275665 3659116 | |
MESH:D004828 | Epilepsies, Partial | Valproic Acid | 3.08 | 3922381 16628512 | |
MESH:D004827 | Epilepsy | Valproic Acid | 2.45 | 20417680 18234410 | |
MESH:D004832 | Epilepsy, Absence | Naloxone | 7.12 | 6254150 | |
MESH:D004832 | Epilepsy, Absence | Valproic Acid | 7.12 | 6254150 6426943 7562514 | |
MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 3.49 | 7750514 | |
MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 3.24 | 3659116 | |
MESH:D004938 | Esophageal Neoplasms | Ethanol | 3.91 | 16704527 | |
MESH:D004938 | Esophageal Neoplasms | Zinc | 3.91 | 16543248 | |
MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 6.65 | 11564622 | |
MESH:D005124 | Eye Abnormalities | Tretinoin | 6.65 | 16938888 9664655 | |
MESH:D005234 | Fatty Liver | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | 72.77 | 14736702 | |
MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 72.77 | 19224547 12795759 61145 12631006 17595544 15959796 16239168 16045604 | |
MESH:D005234 | Fatty Liver | Clofibrate | 72.77 | 19224547 | |
MESH:D005234 | Fatty Liver | Cyclosporine | 72.77 | 19224547 | |
MESH:D005234 | Fatty Liver | Dietary Fats | 72.77 | 17967931 19551842 18296743 19004024 | |
MESH:D005234 | Fatty Liver | Ethanol | 72.77 | 18620774 16409862 19236843 | |
MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 72.77 | 15345470 | |
MESH:D005234 | Fatty Liver | Fish Oils | 72.77 | 18620774 | |
MESH:D005234 | Fatty Liver | Fructose | 72.77 | 18395287 19196556 18641190 | |
MESH:D005234 | Fatty Liver | pirinixic acid | 72.77 | 19236843 20131406 | |
MESH:D005234 | Fatty Liver | rosiglitazone | 72.77 | 19196556 | |
MESH:D005234 | Fatty Liver | Stavudine | 72.77 | 18299183 | |
MESH:D005234 | Fatty Liver | Tamoxifen | 72.77 | 19224547 14986274 | |
MESH:D005234 | Fatty Liver | Tetracycline | 72.77 | 19224547 16917069 | |
MESH:D005234 | Fatty Liver | Valproic Acid | 72.77 | 14986274 19224547 | |
MESH:D005234 | Fatty Liver | Zidovudine | 72.77 | 18299183 | |
MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.82 | 17920746 | |
MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.67 | 16709447 | |
MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 4.47 | 15513904 16946407 15451040 10194807 | |
MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.65 | 11858732 | |
MESH:D005315 | Fetal Diseases | Valproic Acid | 4.04 | 16575769 | |
MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 3.34 | 8888407 18558336 | |
MESH:D005334 | Fever | Ibuprofen | 3.86 | 16997862 | |
MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 3.70 | 14745880 | |
MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 8.70 | 19069698 | |
MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 8.70 | 19069698 | |
MESH:D005354 | Fibrosarcoma | Methylnitrosourea | 4.41 | 11555667 | |
MESH:D005355 | Fibrosis | Carbon Tetrachloride | 29.29 | 18705752 | |
MESH:D005355 | Fibrosis | Cyclosporine | 29.29 | 12639820 12168785 | |
MESH:D005355 | Fibrosis | Dietary Fats | 29.29 | 18296743 | |
MESH:D005355 | Fibrosis | Fructose | 29.29 | 18504504 | |
MESH:D005355 | Fibrosis | Quercetin | 29.29 | 19474275 | |
MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 29.29 | 20067830 | |
MESH:D005355 | Fibrosis | Tretinoin | 29.29 | 17994277 | |
MESH:D005414 | Flatulence | orlistat | 5.80 | 20002075 | |
MESH:D005756 | Gastritis | Acetaminophen | 14.22 | 16983495 | |
MESH:D005756 | Gastritis | Ethanol | 14.22 | 15046732 | |
MESH:D005756 | Gastritis | Zinc | 14.22 | 17241300 | |
MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 3.39 | 8708960 | |
MESH:D005909 | Glioblastoma | Doxorubicin | 8.50 | 17150277 | |
MESH:D005909 | Glioblastoma | Quercetin | 8.50 | 19804834 | |
MESH:D005909 | Glioblastoma | Tretinoin | 8.50 | 17312396 | |
MESH:D005910 | Glioma | Methylnitrosourea | 5.04 | 9825942 | |
MESH:D005910 | Glioma | Quercetin | 5.04 | 17643826 | |
MESH:D018149 | Glucose Intolerance | Fructose | 4.55 | 19165636 | |
MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.75 | 10696789 | |
MESH:D006130 | Growth Disorders | Zinc | 3.37 | 17217573 | |
MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 5.82 | 15692506 | |
MESH:D006258 | Head and Neck Neoplasms | Tretinoin | 5.82 | 16096774 | |
MESH:D006317 | Hearing Loss, Noise-Induced | Tretinoin | 4.31 | 16084493 | |
MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 4.83 | 10048152 11294989 | |
MESH:D006330 | Heart Defects, Congenital | Tretinoin | 4.83 | 14991402 9664655 | |
MESH:D006331 | Heart Diseases | Doxorubicin | 13.13 | 16244372 12587719 16879835 16144979 16330681 16707910 14766674 18674790 17875725 17888722 18006777 16244371 16495754 | |
MESH:D006331 | Heart Diseases | Mitoxantrone | 13.13 | 16019553 | |
MESH:D006331 | Heart Diseases | Streptozocin | 13.13 | 12093613 | |
MESH:D006331 | Heart Diseases | Urethane | 13.13 | 16046796 | |
MESH:D006333 | Heart Failure | Doxorubicin | 12.19 | 17481944 | |
MESH:D006333 | Heart Failure | pirinixic acid | 12.19 | 20558911 | |
MESH:D006333 | Heart Failure | Selenium | 12.19 | 17162251 | |
MESH:D006333 | Heart Failure | Zinc | 12.19 | 17162251 | |
MESH:D006335 | Heart Injuries | Zinc | 4.93 | 17074742 | |
MESH:D016481 | Helicobacter Infections | Zinc | 3.76 | 17241300 | |
MESH:D006394 | Hemangiosarcoma | Doxorubicin | 3.16 | 15692506 | |
MESH:D006402 | Hematologic Diseases | Benzene | 8.52 | 16183116 | |
MESH:D006402 | Hematologic Diseases | Zidovudine | 8.52 | 12579204 | |
MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 3.59 | 15720958 | |
MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.58 | 11000095 | |
MESH:D006505 | Hepatitis | Carbon Tetrachloride | 2.82 | 19900420 19110552 | |
MESH:D006509 | Hepatitis B | Lamivudine | 4.34 | 17703166 | |
MESH:D019694 | Hepatitis B, Chronic | Lamivudine | 4.34 | 15274664 16476009 12044531 15631357 15309715 | |
MESH:D006527 | Hepatolenticular Degeneration | Zinc | 3.88 | 17276780 | |
MESH:D006529 | Hepatomegaly | pirinixic acid | 5.61 | 19176532 16221962 19772884 18467677 | |
MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 5.61 | 16120746 15340226 12621046 | |
MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 2.71 | 7520565 | |
MESH:D006558 | Herpes Genitalis | Estradiol | 4.19 | 15709030 | |
MESH:D006561 | Herpes Simplex | Etoposide | 7.37 | 10809021 | |
MESH:D006561 | Herpes Simplex | resveratrol | 7.37 | 16876885 | |
MESH:D015658 | HIV Infections | Indinavir | 11.31 | 11141242 11363243 15388451 | |
MESH:D015658 | HIV Infections | Lamivudine | 11.31 | 11141242 20032539 9296927 17530837 | |
MESH:D015658 | HIV Infections | Stavudine | 11.31 | 11141242 | |
MESH:D015658 | HIV Infections | Zidovudine | 11.31 | 11141242 20032539 11363243 11698656 17358032 | |
MESH:D006689 | Hodgkin Disease | Doxorubicin | 5.42 | 15147373 18501091 17606976 | |
MESH:D006689 | Hodgkin Disease | Etoposide | 5.42 | 18180244 16200630 16135485 15147373 17606976 | |
MESH:D019584 | Hot Flashes | Estradiol | 2.92 | 17088409 | |
MESH:D006849 | Hydrocephalus | Valproic Acid | 4.04 | 17688650 | |
MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.20 | 16354765 16959395 15340226 18606429 8697196 | |
MESH:D006930 | Hyperalgesia | Acetaminophen | 13.14 | 16870215 | |
MESH:D006930 | Hyperalgesia | Ethanol | 13.14 | 18783367 | |
MESH:D006930 | Hyperalgesia | rosiglitazone | 13.14 | 12083418 | |
MESH:D006930 | Hyperalgesia | Tretinoin | 13.14 | 16870215 | |
MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.70 | 16899240 | |
MESH:D006937 | Hypercholesterolemia | Dietary Fats | 6.73 | 21332399 | |
MESH:D006937 | Hypercholesterolemia | resveratrol | 6.73 | 17188708 | |
MESH:D017681 | Hypereosinophilic Syndrome | Tretinoin | 3.76 | 16778211 | |
MESH:D006943 | Hyperglycemia | pirinixic acid | 6.81 | 20558911 | |
MESH:D006943 | Hyperglycemia | Quercetin | 6.81 | 11834736 18262572 | |
MESH:D006946 | Hyperinsulinism | Fructose | 4.19 | 18563319 14757778 18360027 19008412 15752949 | |
MESH:D006948 | Hyperkinesis | Clozapine | 4.08 | 16046005 | |
MESH:D006949 | Hyperlipidemias | Dietary Fats | 20.76 | 21332399 | |
MESH:D006949 | Hyperlipidemias | Fish Oils | 20.76 | 15752949 | |
MESH:D006949 | Hyperlipidemias | Fructose | 20.76 | 15752949 | |
MESH:D006949 | Hyperlipidemias | orlistat | 20.76 | 21332399 | |
MESH:D006949 | Hyperlipidemias | resveratrol | 20.76 | 16873680 | |
MESH:D006968 | Hypersensitivity, Delayed | Corn Oil | 9.90 | 11484837 | |
MESH:D006968 | Hypersensitivity, Delayed | Fish Oils | 9.90 | 11484837 | |
MESH:D006973 | Hypertension | Benzene | 15.28 | 17940673 | |
MESH:D006973 | Hypertension | Cyclosporine | 15.28 | 10903974 | |
MESH:D006973 | Hypertension | Dexamethasone | 15.28 | 17042910 | |
MESH:D006973 | Hypertension | Fructose | 15.28 | 19008412 14633139 14568997 16843071 14573337 | |
MESH:D006973 | Hypertension | Quercetin | 15.28 | 18356687 | |
MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 15.28 | 18850075 18670907 | |
MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 3.28 | 15338365 | |
MESH:D015228 | Hypertriglyceridemia | Fructose | 8.93 | 19342510 19799862 | |
MESH:D015228 | Hypertriglyceridemia | Triglycerides | 8.93 | 16979400 16238453 | |
MESH:D006984 | Hypertrophy | Ibuprofen | 4.22 | 16672835 | |
MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 3.57 | 17488730 | |
MESH:D007021 | Hypospadias | Ethinyl Estradiol | 3.00 | 16945680 16569931 | |
MESH:D007235 | Infant, Premature, Diseases | Ibuprofen | 4.99 | 16133044 | |
MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 3.84 | 17600658 | |
MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.69 | 12013081 | |
MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 11.24 | 17937319 | |
MESH:D007248 | Infertility, Male | fulvestrant | 11.24 | 11514358 | |
MESH:D007248 | Infertility, Male | Methylnitrosourea | 11.24 | 7193160 | |
MESH:D007248 | Infertility, Male | Triclosan | 11.24 | 20821571 | |
MESH:D007249 | Inflammation | Dexamethasone | 19.70 | 11099482 8960868 | |
MESH:D007249 | Inflammation | Dietary Fats | 19.70 | 20412841 | |
MESH:D007249 | Inflammation | Ibuprofen | 19.70 | 3291741 | |
MESH:D007249 | Inflammation | resveratrol | 19.70 | 16366677 | |
MESH:D007249 | Inflammation | rosiglitazone | 19.70 | 12083418 | |
MESH:D007249 | Inflammation | Tamoxifen | 19.70 | 19457130 | |
MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 19.70 | 12200463 12878042 | |
MESH:D007249 | Inflammation | Triclosan | 19.70 | 9584910 20507366 | |
MESH:D007251 | Influenza, Human | Quercetin | 13.82 | 16624496 | |
MESH:D007251 | Influenza, Human | resveratrol | 13.82 | 16624496 | |
MESH:D007251 | Influenza, Human | Selenium | 13.82 | 16624496 | |
MESH:D007333 | Insulin Resistance | bisphenol A | 30.47 | 16393666 | |
MESH:D007333 | Insulin Resistance | Dietary Fats | 30.47 | 18457598 11836018 | |
MESH:D007333 | Insulin Resistance | Estradiol | 30.47 | 16393666 16627594 | |
MESH:D007333 | Insulin Resistance | Fructose | 30.47 | 14633139 19342510 19586609 14757778 14573337 17133782 19008412 19799862 18981581 18057795 18563319 | |
MESH:D007333 | Insulin Resistance | orlistat | 30.47 | 17201808 | |
MESH:D007333 | Insulin Resistance | Palmitates | 30.47 | 17471172 | |
MESH:D007333 | Insulin Resistance | pirinixic acid | 30.47 | 16306350 | |
MESH:D007333 | Insulin Resistance | rosiglitazone | 30.47 | 16306350 | |
MESH:D007410 | Intestinal Diseases | Tretinoin | 2.97 | 17994277 | |
MESH:D007511 | Ischemia | Zinc | 3.83 | 16584753 | |
MESH:D007569 | Jaw Abnormalities | Ethanol | 12.84 | 15513904 | |
MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 12.84 | 16580747 | |
MESH:D007569 | Jaw Abnormalities | Tretinoin | 12.84 | 15992940 17551590 | |
MESH:D007627 | Keloid | Quercetin | 4.14 | 17086741 | |
MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 3.60 | 15604871 | |
MESH:D017492 | Keratosis, Seborrheic | alitretinoin | 4.81 | 16144296 | |
MESH:D007674 | Kidney Diseases | Acetaminophen | 20.52 | 15629191 12587719 | |
MESH:D007674 | Kidney Diseases | Cyclosporine | 20.52 | 8314463 10903974 18776723 | |
MESH:D007674 | Kidney Diseases | Doxorubicin | 20.52 | 15699352 15369732 16775033 | |
MESH:D007674 | Kidney Diseases | Estradiol | 20.52 | 15618244 | |
MESH:D007674 | Kidney Diseases | Quercetin | 20.52 | 16962696 | |
MESH:D007674 | Kidney Diseases | Streptozocin | 20.52 | 12093613 | |
MESH:D007674 | Kidney Diseases | Zinc | 20.52 | 16960431 | |
MESH:C531755 | Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules | orlistat | 5.80 | 17185156 | |
MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 12.43 | 16707910 | |
MESH:D007676 | Kidney Failure, Chronic | Selenium | 12.43 | 16518626 | |
MESH:D007676 | Kidney Failure, Chronic | Zinc | 12.43 | 16518626 | |
MESH:D007680 | Kidney Neoplasms | 2,4-dinitrotoluene | 20.19 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 20.19 | 16705839 | |
MESH:D007680 | Kidney Neoplasms | Cyclosporine | 20.19 | 12371664 | |
MESH:D007680 | Kidney Neoplasms | Estradiol | 20.19 | 15610895 | |
MESH:D007680 | Kidney Neoplasms | Tamoxifen | 20.19 | 18625569 | |
MESH:D007680 | Kidney Neoplasms | Zidovudine | 20.19 | 12579204 | |
MESH:D007859 | Learning Disorders | Ethanol | 3.41 | 15451040 | |
MESH:D007938 | Leukemia | Benzene | 7.71 | 14694614 17119257 15935818 18335105 | |
MESH:D007938 | Leukemia | Quercetin | 7.71 | 17468513 | |
MESH:D007938 | Leukemia | Tretinoin | 7.71 | 17143497 | |
MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 11.43 | 16085563 | |
MESH:D004915 | Leukemia, Erythroblastic, Acute | troglitazone | 11.43 | 16085563 | |
MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Mitoxantrone | 3.36 | 18172266 | |
MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Zidovudine | 3.66 | 20370541 | |
MESH:D007951 | Leukemia, Myeloid | Benzene | 7.19 | 17506065 | |
MESH:D007951 | Leukemia, Myeloid | Tretinoin | 7.19 | 16482212 19285840 16932348 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Benzene | 4.80 | 19478238 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Tretinoin | 4.80 | 16294345 17596541 19850784 | |
MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 4.80 | 16294345 17596541 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 5.78 | 16087638 | |
MESH:D015473 | Leukemia, Promyelocytic, Acute | Tretinoin | 5.78 | 16331271 17368321 9834237 17506722 17107899 16140955 19035177 19029980 17361223 17217047 16788101 19225113 16823087 12679006 15748426 16935935 17339181 17649720 19075265 17301526 16766008 16891316 17294898 17712046 19642359 | |
MESH:D017880 | Limb Deformities, Congenital | Ethanol | 10.13 | 17676605 | |
MESH:D017880 | Limb Deformities, Congenital | Methylnitrosourea | 10.13 | 15526292 | |
MESH:D017880 | Limb Deformities, Congenital | Tretinoin | 10.13 | 9224671 | |
MESH:D008064 | Lipidoses | Clozapine | 5.97 | 17567588 | |
MESH:D008064 | Lipidoses | Tamoxifen | 5.97 | 17567588 15342952 | |
MESH:D008080 | Liposarcoma | therapeutic | 20372807 | ||
MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 11.49 | 16943688 17157831 11903743 16221502 11408273 17174718 21278145 16239168 17334410 | |
MESH:D008103 | Liver Cirrhosis | Dietary Fats | 11.49 | 18296743 | |
MESH:D008103 | Liver Cirrhosis | Ethanol | 11.49 | 15289165 | |
MESH:D008103 | Liver Cirrhosis | orlistat | 11.49 | 17404856 | |
MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 4.27 | 18295389 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 23.81 | 17823541 17640975 14512876 12741479 15370692 18418968 12546737 12586293 12445418 15650968 16015684 12445421 15931870 17631135 18395914 16192424 17714472 15959796 18054572 18339082 15818738 18187930 18472332 18705752 17557913 12667390 17698563 15996030 12389079 16097048 18006644 17766677 14620537 15052691 15925388 18472094 18412020 15057751 12898905 16116963 17869086 18481824 18376398 18317297 18251166 12632512 14716496 18263696 16638106 20821823 17922224 15876570 12666154 14748882 12632514 16011737 13678700 17900296 18210741 17481882 18205269 18156304 18279442 15893842 10355542 11481614 17761835 15362042 15338365 16027843 17805973 18166357 17708605 18429990 17721639 18277467 15730626 18395095 16248980 18420326 15673190 15123356 16136751 12609069 12649538 12958196 17976157 14716833 17565644 16033810 17944888 17525996 14724832 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 23.81 | 16718785 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 23.81 | 16595196 16439617 | |
MESH:D008106 | Liver Cirrhosis, Experimental | epigallocatechin gallate | 23.81 | 17481882 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 23.81 | 14716833 14659978 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 23.81 | 18166357 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Fenofibrate | 23.81 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Phosphatidylcholines | 23.81 | 16169303 | |
MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 23.81 | 15474484 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 23.81 | 12741479 | |
MESH:D008106 | Liver Cirrhosis, Experimental | rosiglitazone | 23.81 | 17347453 15980055 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 23.81 | 18564211 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 23.81 | 12878042 | |
MESH:D008106 | Liver Cirrhosis, Experimental | Tretinoin | 23.81 | 18397230 16248980 | |
MESH:D008107 | Liver Diseases | Acetaminophen | 2.92 | 12969438 16611625 19014921 11587558 19784758 16610002 19460945 12587719 | |
MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 2.92 | 17285989 16964402 15720792 16246199 15830285 | |
MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 3.84 | 17347304 17207112 | |
MESH:D017093 | Liver Failure | Carbon Tetrachloride | 9.16 | 15123358 | |
MESH:D017093 | Liver Failure | Stavudine | 9.16 | 18299183 | |
MESH:D017114 | Liver Failure, Acute | Acetaminophen | 6.97 | 17185352 16871587 | |
MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 6.97 | 16899240 14706259 | |
MESH:D008113 | Liver Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 28.79 | 16835634 18644402 | |
MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 28.79 | 7678174 | |
MESH:D008113 | Liver Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 28.79 | 15890375 | |
MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 28.79 | 19294768 | |
MESH:D008113 | Liver Neoplasms | Fenofibrate | 28.79 | 18978307 | |
MESH:D008113 | Liver Neoplasms | pirinixic acid | 28.79 | 16377806 20007298 15890375 | |
MESH:D008113 | Liver Neoplasms | Quercetin | 28.79 | 18980244 | |
MESH:D008113 | Liver Neoplasms | resveratrol | 28.79 | 19321006 19812893 20405173 19073162 | |
MESH:D008113 | Liver Neoplasms | Tamoxifen | 28.79 | 16684651 | |
MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 28.79 | 16984957 | |
MESH:D008113 | Liver Neoplasms | Urethane | 28.79 | 17559639 16391232 17093202 | |
MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 19.49 | 2876786 6135515 2876784 | |
MESH:D008114 | Liver Neoplasms, Experimental | Benzene | 19.49 | 12562636 | |
MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 19.49 | 15583823 12014681 | |
MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 19.49 | 16842330 17085340 | |
MESH:D008114 | Liver Neoplasms, Experimental | Fenofibrate | 19.49 | 18775883 18253720 | |
MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 19.49 | 19519916 | |
MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 19.49 | 12151625 | |
MESH:D038061 | Lower Extremity Deformities, Congenital | Methylnitrosourea | 4.65 | 16080182 | |
MESH:D008171 | Lung Diseases | Ozone | 2.78 | 19066396 8266340 | |
MESH:D017563 | Lung Diseases, Interstitial | Benzene | 8.60 | 14698565 | |
MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 8.60 | 17228818 | |
MESH:D055370 | Lung Injury | Ozone | 3.06 | 20417186 | |
MESH:D008175 | Lung Neoplasms | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | 28.59 | 18413838 | |
MESH:D008175 | Lung Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 28.59 | 12438228 14755239 16061637 19931552 18813816 18508827 9255578 15893417 15172992 17139156 16401635 | |
MESH:D008175 | Lung Neoplasms | alitretinoin | 28.59 | 16413115 | |
MESH:D008175 | Lung Neoplasms | Benzene | 28.59 | 12562636 | |
MESH:D008175 | Lung Neoplasms | bexarotene | 28.59 | 17849452 | |
MESH:D008175 | Lung Neoplasms | Dexamethasone | 28.59 | 15824018 11195469 | |
MESH:D008175 | Lung Neoplasms | Doxorubicin | 28.59 | 17418594 6189445 | |
MESH:D008175 | Lung Neoplasms | Isotretinoin | 28.59 | 15899809 | |
MESH:D008175 | Lung Neoplasms | methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate | 28.59 | 17363558 | |
MESH:D008175 | Lung Neoplasms | Methylnitrosourea | 28.59 | 18062963 | |
MESH:D008175 | Lung Neoplasms | Ozone | 28.59 | 7614698 8597069 | |
MESH:D008175 | Lung Neoplasms | Quercetin | 28.59 | 16280456 | |
MESH:D008175 | Lung Neoplasms | Tamoxifen | 28.59 | 18625569 | |
MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 28.59 | 19555203 11884234 | |
MESH:D008175 | Lung Neoplasms | Urethane | 28.59 | 11992545 16337739 10997738 7750092 11807781 10530776 16204055 17195641 12765245 11307925 16289808 16391232 12466968 11246140 17255336 11074608 11893704 11062179 15166089 12117781 12957351 16926031 11544531 15136453 6695378 11497255 10822126 16788158 15902970 17093202 10779650 16007126 11323394 11552296 14587096 | |
MESH:D008175 | Lung Neoplasms | Zidovudine | 28.59 | 18800350 | |
MESH:D008180 | Lupus Erythematosus, Systemic | Silicon Dioxide | 4.18 | 16373255 | |
MESH:D008207 | Lymphatic Metastasis | orlistat | 5.09 | 20805790 18770866 | |
MESH:D008223 | Lymphoma | Benzene | 12.78 | 17584886 17119257 | |
MESH:D008223 | Lymphoma | Doxorubicin | 12.78 | 16098063 | |
MESH:D008223 | Lymphoma | Etoposide | 12.78 | 12854902 12556972 | |
MESH:D008223 | Lymphoma | Methylnitrosourea | 12.78 | 11418001 16257854 | |
MESH:D016393 | Lymphoma, B-Cell | Methylnitrosourea | 7.98 | 14633661 | |
MESH:D016393 | Lymphoma, B-Cell | resveratrol | 7.98 | 17088997 | |
MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 6.56 | 17654614 | |
MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 6.56 | 14749477 | |
MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 3.76 | 15621674 | |
MESH:D016410 | Lymphoma, T-Cell, Cutaneous | bexarotene | 4.34 | 11161223 | |
MESH:D015674 | Mammary Neoplasms, Animal | Benzene | 12.08 | 12562636 | |
MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 12.08 | 15688416 | |
MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 12.08 | 19428831 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Benzene | 39.42 | 11921183 | |
MESH:D008325 | Mammary Neoplasms, Experimental | bexarotene | 39.42 | 19196723 19196722 15591091 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 39.42 | 15458769 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 39.42 | 11807958 16891317 17203775 11408345 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Ibuprofen | 39.42 | 10697514 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Methylnitrosourea | 39.42 | 14999141 11807958 10838139 10767621 17131329 15113128 12931682 15313902 16619500 11751437 17020996 15688392 19196723 14633655 16944150 16051031 16827153 | |
MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 39.42 | 8985016 11606380 | |
MESH:D008325 | Mammary Neoplasms, Experimental | rosiglitazone | 39.42 | 16827153 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Selenium | 39.42 | 15318939 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 39.42 | 14580682 19196722 11731420 19196723 16827153 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Triclosan | 39.42 | 15358634 | |
MESH:D008325 | Mammary Neoplasms, Experimental | Zinc | 39.42 | 12773700 | |
MESH:D020149 | Manganese Poisoning | Estradiol | 9.85 | 19453300 | |
MESH:D020149 | Manganese Poisoning | Tamoxifen | 9.85 | 19453300 | |
MESH:D008527 | Medulloblastoma | Tretinoin | 2.38 | 17453147 | |
MESH:D008545 | Melanoma | marker/mechanism | 18770866 20805790 21213365 | ||
MESH:D008545 | Melanoma | Cerulenin | 16.85 | 20805790 | |
MESH:D008545 | Melanoma | Doxorubicin | 16.85 | 16827129 | |
MESH:D008545 | Melanoma | epigallocatechin gallate | 16.85 | 11746506 17992120 | |
MESH:D008545 | Melanoma | Glucose | 16.85 | 14993021 | |
MESH:D008545 | Melanoma | Isotretinoin | 16.85 | 17237267 | |
MESH:D008545 | Melanoma | orlistat | 16.85 | 20805790 18770866 | |
MESH:D008545 | Melanoma | resveratrol | 16.85 | 17992120 | |
MESH:D008545 | Melanoma | Tamoxifen | 16.85 | 19393235 12393984 | |
MESH:D008545 | Melanoma | Tretinoin | 16.85 | 16752155 | |
MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 3.36 | 15990972 | |
MESH:D008546 | Melanoma, Experimental | Acetaminophen | 2.76 | 19513568 | |
MESH:D008569 | Memory Disorders | Ethanol | 7.42 | 18411066 15451040 | |
MESH:D008569 | Memory Disorders | Methylmercury Compounds | 7.42 | 18436314 | |
MESH:D008591 | Meningomyelocele | Tretinoin | 3.61 | 16940565 | |
MESH:D001523 | Mental Disorders | Clozapine | 5.69 | 16856516 | |
MESH:D001523 | Mental Disorders | Haloperidol | 5.69 | 16856516 | |
MESH:D008654 | Mesothelioma | Doxorubicin | 4.88 | 17638057 | |
MESH:D008654 | Mesothelioma | Selenium | 4.88 | 15107826 | |
MESH:D008659 | Metabolic Diseases | resveratrol | 3.62 | 17112576 | |
MESH:D024821 | Metabolic Syndrome X | Clozapine | 12.09 | 19142101 | |
MESH:D024821 | Metabolic Syndrome X | Fructose | 12.09 | 17261469 18497449 17098227 16815490 19165636 | |
MESH:D024821 | Metabolic Syndrome X | rosiglitazone | 12.09 | 17261469 | |
MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.94 | 16801185 | |
MESH:D008679 | Metaplasia | Ozone | 4.26 | 10496685 | |
MESH:D048629 | Micronuclei, Chromosome-Defective | Zidovudine | 4.99 | 17358032 | |
MESH:D053842 | Microsatellite Instability | Methylnitronitrosoguanidine | 5.06 | 17671175 | |
MESH:D008881 | Migraine Disorders | Valproic Acid | 2.57 | 18765137 18803445 | |
MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.74 | 15792986 | |
MESH:D009069 | Movement Disorders | Methylmercury Compounds | 4.55 | 18436314 | |
MESH:D052016 | Mucositis | Doxorubicin | 3.96 | 17415656 | |
MESH:D009101 | Multiple Myeloma | Benzene | 8.62 | 17119195 | |
MESH:D009101 | Multiple Myeloma | Dexamethasone | 8.62 | 15867202 16118317 15744524 | |
MESH:D009101 | Multiple Myeloma | resveratrol | 8.62 | 16267019 16490592 17935668 17164350 14749477 17049120 | |
MESH:D009134 | Muscular Atrophy, Spinal | epigallocatechin gallate | 9.88 | 17962980 | |
MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 9.88 | 17962980 | |
MESH:D009135 | Muscular Diseases | Bezafibrate | 13.27 | 16239165 | |
MESH:D009135 | Muscular Diseases | orlistat | 13.27 | 18430571 | |
MESH:D009135 | Muscular Diseases | pirinixic acid | 13.27 | 16239165 | |
MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 3.27 | 8888407 | |
MESH:D009164 | Mycobacterium Infections | Indinavir | 8.79 | 21442799 | |
MESH:D009164 | Mycobacterium Infections | orlistat | 8.79 | 21442799 | |
MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 9.20 | 9809623 | |
MESH:D009190 | Myelodysplastic Syndromes | Tretinoin | 9.20 | 17596541 | |
MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 9.20 | 17596541 | |
MESH:D009203 | Myocardial Infarction | Doxorubicin | 9.97 | 15857846 19429709 | |
MESH:D009203 | Myocardial Infarction | pirinixic acid | 9.97 | 19151258 | |
MESH:D009203 | Myocardial Infarction | Quercetin | 9.97 | 19595682 | |
MESH:D009203 | Myocardial Infarction | resveratrol | 9.97 | 17188708 17125593 16525036 16456233 16317513 17015251 | |
MESH:D017202 | Myocardial Ischemia | resveratrol | 6.74 | 17125593 17015251 | |
MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 6.74 | 12213967 | |
MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 10.33 | 16810080 | |
MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 10.33 | 16411023 | |
MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 10.33 | 19207477 | |
MESH:D009205 | Myocarditis | resveratrol | 3.93 | 17322642 | |
MESH:D009336 | Necrosis | 2,4-dinitrotoluene | 7.61 | 18551238 | |
MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 7.61 | 7678174 18551238 | |
MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 4.47 | 18259882 | |
MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 4.47 | 19393235 | |
MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 2.17 | 19410462 | |
MESH:D009369 | Neoplasms | 2,4,5,2',4',5'-hexachlorobiphenyl | 26.64 | 8820588 | |
MESH:D009369 | Neoplasms | alitretinoin | 26.64 | 16946489 | |
MESH:D009369 | Neoplasms | Methylnitrosourea | 26.64 | 15533788 | |
MESH:D009369 | Neoplasms | Mitoxantrone | 26.64 | 16640825 | |
MESH:D009369 | Neoplasms | orlistat | 26.64 | 18710210 | |
MESH:D009369 | Neoplasms | pirinixic acid | 26.64 | 17405874 | |
MESH:D009369 | Neoplasms | Quercetin | 26.64 | 15185748 | |
MESH:D009369 | Neoplasms | Tretinoin | 26.64 | 16594593 16946489 | |
MESH:D009369 | Neoplasms | Urethane | 26.64 | 15625555 | |
MESH:D009369 | Neoplasms | valilactone | 26.64 | 18710210 | |
MESH:D009374 | Neoplasms, Experimental | Methylnitrosourea | 15.35 | 12696579 | |
MESH:D009374 | Neoplasms, Experimental | orlistat | 15.35 | 19381703 | |
MESH:D009374 | Neoplasms, Experimental | resveratrol | 15.35 | 8985016 | |
MESH:D009374 | Neoplasms, Experimental | Urethane | 15.35 | 15582191 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | bexarotene | 8.15 | 19196722 | |
MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 8.15 | 19189210 19196722 19200415 | |
MESH:D009389 | Neovascularization, Pathologic | Estradiol | 7.76 | 17289903 | |
MESH:D009389 | Neovascularization, Pathologic | orlistat | 7.76 | 17012255 | |
MESH:D009395 | Nephritis, Interstitial | Ibuprofen | 8.24 | 6375363 | |
MESH:D009395 | Nephritis, Interstitial | Tetracycline | 8.24 | 9884423 | |
MESH:D009401 | Nephrosis | Doxorubicin | 3.96 | 16899518 16636307 | |
MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 3.60 | 17954296 | |
MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 6.92 | 18481113 19348381 | |
MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 6.92 | 16889571 15640375 | |
MESH:D009410 | Nerve Degeneration | Ibuprofen | 6.67 | 10961664 | |
MESH:D009410 | Nerve Degeneration | Rotenone | 6.67 | 15790535 18619942 17356569 | |
MESH:D009421 | Nervous System Malformations | bisphenol A | 17.01 | 16427766 11399458 | |
MESH:D009421 | Nervous System Malformations | Estradiol | 17.01 | 16427766 11399458 | |
MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 17.01 | 14600291 | |
MESH:D009421 | Nervous System Malformations | Tretinoin | 17.01 | 9125849 | |
MESH:D009436 | Neural Tube Defects | Benzene | 8.77 | 15643154 | |
MESH:D009436 | Neural Tube Defects | Tretinoin | 8.77 | 9142499 | |
MESH:D009436 | Neural Tube Defects | Valproic Acid | 8.77 | 16359493 8888407 | |
MESH:D009442 | Neurilemmoma | Methylnitrosourea | 4.66 | 11555667 | |
MESH:D009447 | Neuroblastoma | Doxorubicin | 5.68 | 15555623 | |
MESH:D009447 | Neuroblastoma | Isotretinoin | 5.68 | 17368321 | |
MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 6.04 | 18514411 | |
MESH:D019636 | Neurodegenerative Diseases | resveratrol | 6.04 | 17652729 | |
MESH:D020078 | Neurogenic Inflammation | Quercetin | 8.14 | 17929310 | |
MESH:D020078 | Neurogenic Inflammation | resveratrol | 8.14 | 17929310 | |
MESH:D052556 | Niemann-Pick Disease, Type C | Clofibrate | 4.13 | 9802331 | |
MESH:C541083 | Non-alcoholic Fatty Liver Disease | orlistat | 4.80 | 17404856 | |
MESH:D009765 | Obesity | 4-methylene-2-octyl-5-oxofuran-3-carboxylic acid | 13.90 | 14736702 | |
MESH:D009765 | Obesity | Clozapine | 13.90 | 19142110 18515891 | |
MESH:D009765 | Obesity | Dietary Fats | 13.90 | 17217161 18674790 20132043 16723640 21332399 18457598 20518802 11836018 19632207 | |
MESH:D009765 | Obesity | Fructose | 13.90 | 18585860 17707055 | |
MESH:D009765 | Obesity | orlistat | 13.90 | 18773755 20599501 20065556 20518802 16938137 21438711 19046740 20002075 19461584 20540997 21442799 19207292 | |
MESH:D009765 | Obesity | pirinixic acid | 13.90 | 20558911 | |
MESH:D009784 | Occupational Diseases | 2,4-dinitrotoluene | 10.94 | 12819281 16049721 | |
MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 10.94 | 16049721 | |
MESH:D009784 | Occupational Diseases | Benzene | 10.94 | 17178637 15727169 17479406 15935809 17119257 16737584 15576619 15913788 15612468 | |
MESH:D010003 | Osteoarthritis | Ibuprofen | 3.57 | 7009135 | |
MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 7.65 | 19495926 | |
MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 7.65 | 17513867 | |
MESH:D012516 | Osteosarcoma | Doxorubicin | 3.43 | 15930896 | |
MESH:D010049 | Ovarian Diseases | bisphenol A | 4.16 | 11985600 | |
MESH:D010051 | Ovarian Neoplasms | Benzene | 14.20 | 12562636 | |
MESH:D010051 | Ovarian Neoplasms | Estradiol | 14.20 | 19401270 | |
MESH:D010051 | Ovarian Neoplasms | Mifepristone | 14.20 | 16525653 | |
MESH:D010051 | Ovarian Neoplasms | Quercetin | 14.20 | 19005980 | |
MESH:D010051 | Ovarian Neoplasms | Tretinoin | 14.20 | 16936753 | |
MESH:D010051 | Ovarian Neoplasms | Urethane | 14.20 | 16391232 | |
MESH:D010146 | Pain | Acetaminophen | 7.38 | 16870215 | |
MESH:D010146 | Pain | Ibuprofen | 7.38 | 3291741 | |
MESH:D010146 | Pain | Tretinoin | 7.38 | 16870215 | |
MESH:D010149 | Pain, Postoperative | Ibuprofen | 4.31 | 16678543 | |
MESH:D010190 | Pancreatic Neoplasms | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 18.82 | 12384795 | |
MESH:D010190 | Pancreatic Neoplasms | Ethanol | 18.82 | 12384795 | |
MESH:D010190 | Pancreatic Neoplasms | Etoposide | 18.82 | 19003803 | |
MESH:D010190 | Pancreatic Neoplasms | Ibuprofen | 18.82 | 12384795 | |
MESH:D010190 | Pancreatic Neoplasms | Methylnitrosourea | 18.82 | 16965848 | |
MESH:D010190 | Pancreatic Neoplasms | Quercetin | 18.82 | 16965848 | |
MESH:D010190 | Pancreatic Neoplasms | Tretinoin | 18.82 | 15976015 | |
MESH:D010195 | Pancreatitis | Fatty Acids, Nonesterified | 7.12 | 18983441 | |
MESH:D010195 | Pancreatitis | orlistat | 7.12 | 20065556 16938137 | |
MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.91 | 11578682 | |
MESH:D010300 | Parkinson Disease | Rotenone | 2.61 | 11535288 16140633 11445065 16412576 19114014 18619942 15451049 18191903 19232380 | |
MESH:D020734 | Parkinsonian Disorders | Rotenone | 3.35 | 15795934 15574749 15927086 18197244 | |
MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.40 | 12520081 | |
MESH:D010391 | Pemphigoid, Bullous | Tetracycline | 4.59 | 11026799 | |
MESH:D010538 | Peritonitis | Ozone | 3.33 | 16369182 | |
MESH:D003557 | Phyllodes Tumor | Doxorubicin | 4.31 | 17983394 | |
MESH:D010911 | Pituitary Neoplasms | Urethane | 4.60 | 16391232 | |
MESH:D010954 | Plasmacytoma | Selenium | 4.05 | 15087411 | |
MESH:D010997 | Pleural Neoplasms | Doxorubicin | 4.31 | 17638057 | |
MESH:D011014 | Pneumonia | Ozone | 3.57 | 18929643 18381685 18007984 | |
MESH:D011085 | Polycystic Ovary Syndrome | orlistat | 4.54 | 17201808 | |
MESH:D017499 | Porokeratosis | alitretinoin | 5.16 | 16144296 | |
MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 2.77 | 18163543 | |
MESH:D011230 | Precancerous Conditions | Corn Oil | 11.39 | 14668109 | |
MESH:D011230 | Precancerous Conditions | Cyclosporine | 11.39 | 12371664 | |
MESH:D011230 | Precancerous Conditions | Quercetin | 11.39 | 19056647 | |
MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 3.01 | 21297632 | |
MESH:D011225 | Pre-Eclampsia | Zinc | 3.51 | 17114810 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | bisphenol A | 27.34 | 10548101 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Isotretinoin | 27.34 | 18769834 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Methylmercury Compounds | 27.34 | 18436314 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 27.34 | 16679765 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 27.34 | 11896295 11399792 11118676 11222880 | |
MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 27.34 | 20603192 | |
MESH:D017096 | Prion Diseases | Tetracycline | 4.58 | 10903871 | |
MESH:D011470 | Prostatic Hyperplasia | Calcitriol | 3.95 | 15572423 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | bisphenol A | 8.05 | 20887781 | |
MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 8.05 | 20887781 | |
MESH:D011471 | Prostatic Neoplasms | bisphenol A | 3.42 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Calcitriol | 3.42 | 16289102 18247401 16644109 15754350 12479363 | |
MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 3.42 | 16888761 18437689 15749863 15897917 16868541 16729912 | |
MESH:D011471 | Prostatic Neoplasms | Estradiol | 3.42 | 16740699 | |
MESH:D011471 | Prostatic Neoplasms | Etoposide | 3.42 | 17172428 | |
MESH:D011471 | Prostatic Neoplasms | Ibuprofen | 3.42 | 17409433 | |
MESH:D011471 | Prostatic Neoplasms | Methylnitrosourea | 3.42 | 15682402 12376480 | |
MESH:D011471 | Prostatic Neoplasms | Quercetin | 3.42 | 14715546 17292933 | |
MESH:D011471 | Prostatic Neoplasms | resveratrol | 3.42 | 17804756 16731767 17636462 15767336 17675339 17718901 | |
MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 3.42 | 15067354 | |
MESH:D011471 | Prostatic Neoplasms | Zinc | 3.42 | 12429649 16606632 16517595 16700911 | |
MESH:D011507 | Proteinuria | Ibuprofen | 6.96 | 6375363 | |
MESH:D011507 | Proteinuria | Tretinoin | 6.96 | 16636307 | |
MESH:D011537 | Pruritus | Ethinyl Estradiol | 7.30 | 15861022 16919318 | |
MESH:D011537 | Pruritus | Naloxone | 7.30 | 15861022 | |
MESH:D019310 | Pseudolymphoma | Valproic Acid | 3.70 | 11422049 12752131 | |
MESH:D011565 | Psoriasis | Cyclosporine | 1.86 | 16882103 | |
MESH:D011595 | Psychomotor Agitation | Haloperidol | 4.15 | 11575062 | |
MESH:D011596 | Psychomotor Disorders | Isotretinoin | 5.09 | 18769834 | |
MESH:D011618 | Psychotic Disorders | Clozapine | 7.03 | 15331141 | |
MESH:D011618 | Psychotic Disorders | Haloperidol | 7.03 | 11575062 | |
MESH:D011625 | Pterygium | Tretinoin | 3.96 | 16723453 | |
MESH:D011629 | Puberty, Precocious | bisphenol A | 3.96 | 10548101 | |
MESH:D011658 | Pulmonary Fibrosis | Silicon Dioxide | 5.49 | 17365031 12193738 14975940 | |
MESH:D011658 | Pulmonary Fibrosis | troglitazone | 5.49 | 18162602 | |
MESH:D012035 | Refsum Disease | orlistat | 5.24 | 20871815 | |
MESH:D051437 | Renal Insufficiency | Doxorubicin | 3.42 | 17922066 | |
MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.74 | 16325855 | |
MESH:D015427 | Reperfusion Injury | pirinixic acid | 4.94 | 19058328 | |
MESH:D015427 | Reperfusion Injury | resveratrol | 4.94 | 16317513 16314181 15827377 17058453 17520802 | |
MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 3.26 | 11700416 18379247 | |
MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 3.04 | 18990726 | |
MESH:D012162 | Retinal Degeneration | Methylnitrosourea | 7.21 | 18172121 18155124 | |
MESH:D012162 | Retinal Degeneration | Zinc | 7.21 | 16584753 | |
MESH:D012175 | Retinoblastoma | Methylnitrosourea | 4.66 | 11555667 | |
MESH:D012206 | Rhabdomyolysis | Lamivudine | 4.71 | 9296927 | |
MESH:D012208 | Rhabdomyosarcoma | Tretinoin | 8.30 | 16283617 16116481 | |
MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 8.30 | 19155313 | |
MESH:D012509 | Sarcoma | Doxorubicin | 3.26 | 18313854 15625365 15675481 16767912 17710206 17203757 | |
MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 7.94 | 14601052 16326096 | |
MESH:D012512 | Sarcoma, Ewing's | Etoposide | 7.94 | 14601052 | |
MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.96 | 17846226 | |
MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.70 | 16862918 | |
MESH:D012559 | Schizophrenia | Clozapine | 4.52 | 11151749 20452607 17123785 20521326 19369910 20107430 16141801 18855531 20521320 17726453 18806925 11763009 20580759 17667964 20168265 | |
MESH:D012559 | Schizophrenia | Haloperidol | 4.52 | 1830565 19369910 18513383 20107430 | |
MESH:D012559 | Schizophrenia | Valproic Acid | 4.52 | 15737665 19110320 | |
MESH:D012640 | Seizures | 2,4-dinitrotoluene | 9.12 | 18551238 | |
MESH:D012640 | Seizures | 2,6-dinitrotoluene | 9.12 | 18551238 | |
MESH:D012640 | Seizures | Ethanol | 9.12 | 9754883 | |
MESH:D012640 | Seizures | Valproic Acid | 9.12 | 15475178 17978042 11738929 3137016 16876388 11044598 1511512 14763951 | |
MESH:D012829 | Silicosis | Silicon Dioxide | 6.36 | 18666137 | |
MESH:D012878 | Skin Neoplasms | Doxorubicin | 16.33 | 15692506 | |
MESH:D012878 | Skin Neoplasms | Glucose | 16.33 | 14993021 | |
MESH:D012878 | Skin Neoplasms | resveratrol | 16.33 | 8985016 15837718 | |
MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 16.33 | 16192470 | |
MESH:D012878 | Skin Neoplasms | Tretinoin | 16.33 | 16467112 | |
MESH:D012878 | Skin Neoplasms | Urethane | 16.33 | 11807781 | |
MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.76 | 17203757 16767912 15625365 | |
MESH:D013088 | Spermatocele | Ethinyl Estradiol | 8.77 | 16709447 | |
MESH:D013088 | Spermatocele | Tamoxifen | 8.77 | 16709447 | |
MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 3.22 | 19457130 | |
MESH:D016135 | Spinal Dysraphism | Valproic Acid | 3.11 | 19490988 | |
MESH:D013226 | Status Epilepticus | Valproic Acid | 3.70 | 12833885 | |
MESH:D013272 | Stomach Diseases | Dexamethasone | 3.50 | 15472012 | |
MESH:D013274 | Stomach Neoplasms | Benzene | 8.13 | 12562636 | |
MESH:D013274 | Stomach Neoplasms | Ethanol | 8.13 | 18456281 | |
MESH:D013274 | Stomach Neoplasms | Methylnitrosourea | 8.13 | 16257854 18593901 15930296 | |
MESH:D013274 | Stomach Neoplasms | orlistat | 8.13 | 19381703 | |
MESH:D013274 | Stomach Neoplasms | Tretinoin | 8.13 | 17261132 | |
MESH:D013274 | Stomach Neoplasms | troglitazone | 8.13 | 15930296 | |
MESH:D013274 | Stomach Neoplasms | Zidovudine | 8.13 | 17696246 | |
MESH:D013276 | Stomach Ulcer | Dexamethasone | 5.13 | 15138204 | |
MESH:D013276 | Stomach Ulcer | Ethanol | 5.13 | 17189318 11906479 9562338 16755016 9211565 17918041 | |
OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.74 | 16321402 | |
MESH:D019966 | Substance-Related Disorders | bisphenol A | 3.17 | 16684133 16045194 | |
MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 3.52 | 9754883 | |
MESH:D017180 | Tachycardia, Ventricular | Haloperidol | 3.92 | 20210726 | |
MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.85 | 11994571 | |
MESH:D013927 | Thrombosis | Ethinyl Estradiol | 2.44 | 15669648 | |
MESH:D013953 | Thymus Neoplasms | Benzene | 9.48 | 10850423 | |
MESH:D013953 | Thymus Neoplasms | Methylnitrosourea | 9.48 | 11418001 | |
MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 9.71 | 12697716 | |
MESH:D013959 | Thyroid Diseases | Triclosan | 9.71 | 19910387 | |
MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 8.33 | 16010429 17909728 | |
MESH:D013964 | Thyroid Neoplasms | Methylnitrosourea | 8.33 | 7505956 3078959 | |
MESH:D013964 | Thyroid Neoplasms | Tretinoin | 8.33 | 17045167 16026305 | |
MESH:D013978 | Tibial Fractures | Estradiol | 3.84 | 19048282 | |
MESH:D014062 | Tongue Neoplasms | resveratrol | 12.40 | 16227395 | |
MESH:D014062 | Tongue Neoplasms | Tretinoin | 12.40 | 16051514 | |
MESH:D014062 | Tongue Neoplasms | Zinc | 12.40 | 16543248 | |
MESH:D014178 | Translocation, Genetic | Valproic Acid | 4.39 | 17262798 | |
MESH:D014376 | Tuberculosis | Tretinoin | 2.65 | 16040207 | |
MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 3.69 | 3119515 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,4-dinitrotoluene | 11.35 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 11.35 | 16049721 | |
MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 11.35 | 17653716 | |
MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 11.35 | 16720314 | |
MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 11.35 | 8653321 16712894 17572228 | |
MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 3.83 | 8888407 | |
MESH:D014571 | Urologic Neoplasms | 2,4-dinitrotoluene | 9.25 | 10091137 | |
MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 9.25 | 10091137 | |
MESH:D014581 | Urticaria | Acetaminophen | 2.22 | 10982225 | |
MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 7.10 | 17473185 | |
MESH:D002583 | Uterine Cervical Neoplasms | Tretinoin | 7.10 | 16129372 | |
MESH:D014591 | Uterine Diseases | bisphenol A | 4.16 | 14652134 | |
MESH:D014594 | Uterine Neoplasms | Benzene | 11.57 | 12562636 | |
MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 11.57 | 14692618 | |
MESH:D014594 | Uterine Neoplasms | resveratrol | 11.57 | 17044934 | |
MESH:D014604 | Uveal Neoplasms | Tretinoin | 3.77 | 16752155 | |
MESH:D014605 | Uveitis | Cyclosporine | 8.98 | 1336536 | |
MESH:D014605 | Uveitis | Dexamethasone | 8.98 | 1336536 | |
MESH:D014625 | Vaginal Neoplasms | Zidovudine | 3.95 | 12579204 | |
MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.75 | 12125929 | |
MESH:D019043 | Vascular Neoplasms | Urethane | 5.07 | 10620525 | |
MESH:D020301 | Vasospasm, Intracranial | Ibuprofen | 4.37 | 19057314 | |
MESH:D014689 | Venous Insufficiency | coumarin | 4.93 | 12708602 | |
MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.79 | 15869587 14671159 | |
MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 7.67 | 16364871 17638931 17334414 17678736 | |
MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 7.67 | 17488730 | |
MESH:D014820 | Vitiligo | Tretinoin | 3.27 | 16761959 | |
MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.40 | 15886252 | |
MESH:D015430 | Weight Gain | Clozapine | 7.44 | 20564506 20521320 16141801 20107430 16402076 17502770 | |
MESH:D015430 | Weight Gain | Dietary Fats | 7.44 | 16723640 | |
MESH:D015431 | Weight Loss | Clozapine | 4.25 | 17933447 | |
MESH:D009396 | Wilms Tumor | Tretinoin | 3.25 | 16287080 | |
MESH:D014985 | Xerophthalmia | Cyclosporine | 3.60 | 17120751 |
Pathway ID | Pathway Name |
---|---|
KEGG:00061 | Fatty acid biosynthesis |
KEGG:04910 | Insulin signaling pathway |
REACT:1505 | Integration of energy metabolism |
KEGG:01100 | Metabolic pathways |
REACT:22258 | Metabolism of lipids and lipoproteins |
REACT:11193 | Metabolism of vitamins and cofactors |